GSEP
TMO icon

Golden State Equity Partners’s Thermo Fisher Scientific TMO Stock Holding History

Golden State Equity Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,319
Closed -$2.61M – 1616
2026
Q1 		$2.61M Buy
5,319
+2,685
+102% +$1.46M 0.2% 118
2025
Q4 		$1.53M Buy
2,634
+37
+1% +$20.9K 0.25% 84
2025
Q3 		$1.26M Sell
2,597
-421
-14% -$196K 0.21% 116
2025
Q2 		$1.22M Buy
3,018
+2,047
+211% +$856K 0.23% 103
2025
Q1 		$483K Buy
971
+22
+2% +$11.9K 0.1% 248
2024
Q4 		$494K Sell
949
-57
-6% -$31.3K 0.09% 238
2024
Q3 		$622K Buy
1,006
+387
+63% +$229K 0.1% 220
2024
Q2 		$342K Buy
+619
New +$355K 0.07% 297
2023
Q4 		$346K Buy
+651
New +$315K 0.08% 251
2023
Q3 		– Sell
-386
Closed -$201K – 354
2023
Q2 		$201K Buy
+386
New +$208K 0.06% 347
2022
Q1 		– Sell
-952
Closed -$635K – 221
2021
Q4 		$635K Buy
+952
New +$594K 0.32% 77

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Golden State Equity Partners's TMO Position: Q2 2026 in Review

Golden State Equity Partners sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 5,319 shares — an estimated $2.61M sold.

Golden State Equity Partners first reported a position in TMO in Q4 2021 and held it in 11 quarters. The position peaked at $2.61M in Q1 2026. 2,626 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Golden State Equity Partners reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Golden State Equity Partners sold 5,319 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.61M.
  • Golden State Equity Partners first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 11 quarters.
  • Golden State Equity Partners's Thermo Fisher Scientific position peaked at $2.61M in Q1 2026.
  • 2,626 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Golden State Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.